Tumor progression and metastasis are in part driven by proliferating microvessels that provide oxygen and nutrients to the growing cancer cells. Angiogenic vessels exert an instructive role as a vascular niche by providing paracrine and angiocrine modes of regulation which include secretion and processing of various growth factors and extracellular matrix constituents that in turn influence tumor and endothelial cells in a bidirectional way. Perlecan, a major heparan sulfate proteoglycan secreted by endothelial cells, is a complex regulator of vascular biology and tumor angiogenesis. Perlecan shows a clear functional dichotomy. The parent proteoglycan is pro-angiogenic by acting as a co-receptor for FGF2 and VEGFA via the N-terminal heparin sulfate chains. In contrast, the C-terminal portion of perlecan, named endorepellin, is anti-angiogenic. We have recently discovered that endorepellin binds with high affinity to both ?2?1 integrin and VEGFR2. This dual receptor binding induces co-internalization and physical downregulation of both receptors, activation of SHP-1 and attenuation of VEGFA transcription. These findings provide a new paradigm for the activity of an anti-angiogenic protein and mechanistically explain the specificity of endorepellin for endothelial cells, the only cells that simultaneously express both ?2?1 integrin and VEGFR2. Our long-term objectives are to expand these observations by investigating the binding mode of endorepellin and its various LG modules to the ectodomain of VEGFR2, and decipher the downstream signaling pathway evoked by this natural antagonist of two major angiogenic receptors. Specifically we plan to: [1] Investigate the precise mode through which endorepellin and its LG modules bind to the ectodomain of VEGFR2. [2] Decipher the downstream signaling pathways evoked by endorepellin on vascular endothelial cells, and [3] Generate novel mouse models of tumorigenesis where endorepellin and perlecan are conditionally overexpressed or ablated, respectively, in the endothelia of growing tumors. The expected results should generate a coherent and unified mode of action for endorepellin, identify new target proteins involved in its signaling pathway which could be potential novel targets for anti-angiogenesis therapy, and establish its in vivo role as an anti-angiogenic factor using unambiguous gain- and loss-of-function experiments through endothelial cell-specific gene targeting.

Public Health Relevance

This proposal is based on the discovery that endorepellin, a fragment of perlecan, exhibits potent angiostatic activity via a dual receptor antagonism to regulate angiogenesis. Deciphering the precise mode of action for endorepellin and being able to directly target established tumor vasculature would be of substantial benefit to future anti-angiogenic therapies, not only for cancer but also for other pathologies where angiogenesis plays a pivotal role.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Intercellular Interactions Study Section (ICI)
Program Officer
Woodhouse, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Thomas Jefferson University
Schools of Medicine
United States
Zip Code
Nastase, Madalina V; Iozzo, Renato V; Schaefer, Liliana (2014) Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta 1840:2460-70
Lord, Megan S; Chuang, Christine Y; Melrose, James et al. (2014) The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol 35:112-22
Wu, Zhiping; Horgan, Casie E; Carr, Olivia et al. (2014) Biglycan and decorin differentially regulate signaling in the fetal membranes. Matrix Biol 35:266-75
Neill, Thomas; Torres, Annabel; Buraschi, Simone et al. (2014) Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor ? coactivator-1? (PGC-1?) and mitostatin. J Biol Chem 289:4952-68
Neill, Thomas; Schaefer, Liliana; Iozzo, Renato V (2014) Instructive roles of extracellular matrix on autophagy. Am J Pathol 184:2146-53
Goyal, Atul; Neill, Thomas; Owens, Rick T et al. (2014) Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. Matrix Biol 34:46-54
Moreth, Kristin; Frey, Helena; Hubo, Mario et al. (2014) Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 35:143-51
Hsieh, Louise Tzung-Harn; Nastase, Madalina-Viviana; Zeng-Brouwers, Jinyang et al. (2014) Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol 54:223-35
Nikolovska, Katerina; Renke, Jana K; Jungmann, Oliver et al. (2014) A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. Matrix Biol 35:91-102
Poluzzi, Chiara; Casulli, Joshua; Goyal, Atul et al. (2014) Endorepellin evokes autophagy in endothelial cells. J Biol Chem 289:16114-28

Showing the most recent 10 out of 129 publications